# Open-Label Study of Oral Treprostinil in Digital Ulcers

> **NCT00848107** · PHASE2 · TERMINATED · sponsor: **United Therapeutics** · enrollment: 115 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** treprostinil diethanolamine

## Key facts

- **NCT ID:** NCT00848107
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 115 (ACTUAL)
- **Why stopped:** The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled TDE-DU-201 study did not meet its primary efficacy objective.
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848107, "Open-Label Study of Oral Treprostinil in Digital Ulcers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00848107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*